Derma Sciences Inc

Type: Company
Name: Derma Sciences Inc
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Blog: Insider Trading Scandal Threatens LHA's Future

In the understatement of the year, Keith Lippert said it is “devastating” news that a key executive at 30-year-old Lippert/Heilshorn & Assocs. is charged with 13 counts of insider trading resulting in illicit gains of $1M.He downplayed the gravity of ... [Published Odwyer PR Daily - Aug 27 2014]
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

Research and Markets: OpportunityAnalyzer: Diabetic Foot Ulcers - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update

Research and MarketsFor the past 15 years, Regranex (becaplermin) has been the only pharmacologic wound-healing agent available; however, it is rarely used due a perceived lack of efficacy.The DFU market is now set to enter an exciting phase with the ... [Published Stock Nod - Aug 26 2014]
First reported Aug 22 2014 - Updated Aug 22 2014 - 1 reports

Derma Sciences Sets New 1-Year Low at $8.41 (DSCI)

Derma Sciences (NASDAQ:DSCI) reached a new 52-week low on Friday , AnalystRatingsNetwork reports. The company traded as low as $8.41 and last traded at $8.50, with a volume of 45,789 shares changing hands. The stock had previously closed at $8.56.Several ... [Published American Banking News - Aug 22 2014]
First reported Aug 22 2014 - Updated Aug 22 2014 - 1 reports

New 52-Week Low Could Prompt More Insider Buying At DSCI

In trading on Friday, shares of Derma Sciences Inc. (DSCI) touched a new 52-week low of $8.41/share.. ... [Published Securities Technology Monitor - Aug 22 2014]
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

Global Wound Care Market to Post 3.2% CAGR Through 2019, Says MarketsandMarkets in Its New Report Published at MarketPublishers.com

The world wound care market is expected to grow from USD 15.6 billion in 2014 and reach USD 18.3 billion by 2019, posting a CAGR of 3.2% during the forecast period. The drivers of such growth include governments’ contribution to the development of wound ... [Published Bio-Medicine - Aug 21 2014]
Entities: CAGR, Ethicon Inc., Market
First reported Aug 12 2014 - Updated Aug 13 2014 - 3 reports

Derma Sciences to Present at Canaccord Genuity 34th Annual Growth Conference on August 14

PRINCETON, N.J.--(EON: Enhanced Online News)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound care, announced today that Barry Wolfenson, the Company’s Group President, Advanced Wound Care and Pharmaceutical ... [Published EON Science - Aug 12 2014]
First reported Aug 07 2014 - Updated Aug 08 2014 - 1 reports

Healthcare Review: Derma Sciences, Dynavax Technologies, Curis, Lexicon Pharmaceuticals, Emergent BioSolutions

:50 U.S. stocks edged lower in early afternoon trading as investors assessed the latest company earnings and the outlook for the economy.Investors are still troubled by the potential for escalating tensions between Russia and the West over Ukraine. ... [Published BioMedReports - Aug 07 2014]
First reported Aug 07 2014 - Updated Aug 08 2014 - 3 reports

Derma Sciences PT Lowered to $18.00 (DSCI)

Stock analysts at Canaccord Genuity reduced their target price on shares of Derma Sciences (NASDAQ:DSCI)Shares of Derma Sciences (NASDAQ:DSCI) opened at 9.02 on Friday. Derma Sciences has a 52-week low of $8.45 and a 52-week high of $15.51. The stock ... [Published American Banking News - Forex - Aug 08 2014]
First reported Aug 07 2014 - Updated Aug 07 2014 - 2 reports

Derma Sciences Reports Second Quarter Financial Results

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the three and six months ended June 30, 2014. Highlights of ... [Published Investor's Business Daily - Aug 07 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 2 reports

Derma Sciences announces Veterans Administration adds AMNIOEXCEL® to its Federal Supply Schedule

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound care, announces that AMNIOEXCEL®, its novel human amniotic membrane allograft, has been approved by the Veterans Administration ... [Published Business Wire Technology News - Jul 22 2014]
First reported Jun 13 2014 - Updated Jun 13 2014 - 3 reports

Derma Sciences, Inc. to Webcast June 17th Analyst Day

PRINCETON, N.J.--(EON: Enhanced Online News)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, announces it will be webcasting its Analyst Day event to be held June 17 in New York City. The program’s ... [Published EON Science - Jun 13 2014]
First reported May 08 2014 - Updated May 09 2014 - 3 reports

Derma Sciences Reports First Quarter Financial Results

PRINCETON, N.J.--(EON: Enhanced Online News)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the three months ended March 31, 2014. Highlights ... [Published EON Business - May 08 2014]

Quotes

Securities and Exchange New York regional director Andrew Calamari hit the right note, saying, "Employees of IR firms have access to sensitive information about their clients, and exploiting that information for personal gain is not an option."
New cutting-edge research report " Wound Care Market by Type (Traditional (Wound Closure, Anti infective), Basic (Films, Cleansing), Advanced (Hydrogels, Hydrocolloids, Alginate, Collagen), Active (Artificial Skin & Skin Substitutes), Pressure Relief Devices, NPWT) - Global Forecast to 2019 " drawn up by MarketsandMarkets is now available at MarketPublishers.com
The new report titled, "Global advanced wound care and closure market (types, applications, end user and geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" , suggests that the global advanced wound care and closure market will reach $20.5 billion by 2020, registering a CAGR of 8.0% from 2014 to 2020
According to the new research report  " Wound Ca re Market by Type (Traditional"

More Content

All (55) | News (20) | Reports (0) | Blogs (35) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Diabetic Foot Ulcers Market Outlook to 2017 [Published MyNewsDesk - Aug 28 2014]
Blog: Insider Trading Scandal Threatens LHA's F... [Published Odwyer PR Daily - Aug 27 2014]
Research and Markets: OpportunityAnalyzer: Diab... [Published Stock Nod - Aug 26 2014]
OpportunityAnalyzer: Diabetic Foot Ulcers - Opp... [Published Individual.com - Aug 26 2014]
Derma Sciences Sets New 1-Year Low at $8.41 (DSCI) [Published American Banking News - Aug 22 2014]
New 52-Week Low Could Prompt More Insider Buyin... [Published Securities Technology Monitor - Aug 22 2014]
Global Wound Care Market to Post 3.2% CAGR Thro... [Published Bio-Medicine - Aug 21 2014]
Global Wound Care Market to Post 3.2% CAGR Thro... [Published CBS Detroit - Aug 21 2014]
Global Advanced Wound Care and Closure Market (... [Published The CW11 - Aug 19 2014]
Top Analysts Action: MRVL, NTAP, PFSW, ARUN, FLXN [Published BayStreet.ca - Aug 14 2014]
Derma Sciences to Present at Canaccord Genuity ... [Published EON Science - Aug 12 2014]
Derma Sciences to Present at Canaccord Genuity ... [Published Business Wire Science: Science News - Aug 12 2014]
Derma Sciences to Present at Canaccord Genuity ... [Published Business Wire Health News - Aug 12 2014]
Derma Sciences PT Lowered to $18.00 (DSCI) [Published American Banking News - Forex - Aug 08 2014]
Derma Sciences (DSCI) Announces Quarterly Earni... [Published American Banking News - Earnings - Aug 07 2014]
Healthcare Review: Derma Sciences, Dynavax Tech... [Published BioMedReports - Aug 07 2014]
Derma Sciences Reports Second Quarter Financial... [Published Investor's Business Daily - Aug 07 2014]
Derma Sciences beats by $0.12, misses on revenue [Published Seeking Alpha - Aug 07 2014]
Derma Sciences Reports Second Quarter Financial... [Published Business Wire Health News - Aug 07 2014]
Wound Care Market Worth $18.3 Billion by 2019 [Published CEOWorld Magazine - Aug 01 2014]
Derma Sciences to Hold Second Quarter Financial... [Published Business Wire Health News - Aug 01 2014]
Derma Sciences Reports VA OKs Amnioexcel for Fe... [Published Pharmacy Choice - Jul 29 2014]
COMVITA : Derma Sciences CEO Discusses Continue... [Published 4 Traders - Jul 28 2014]
Bioheart Announces World's First Combination St... [Published BioMedReports - Jul 26 2014]
Derma Sciences CEO Discusses Continued Growth o... [Published Business Wire Health News - Jul 25 2014]
Derma Sciences announces Veterans Administratio... [Published Business Wire Technology News - Jul 22 2014]
Derma Sciences announces Veterans Administratio... [Published Business Wire Health News - Jul 22 2014]
Derma Sciences CEO on exciting new wound drug [Published Latest Econwatch Headlines - CBS News - Jun 21 2014]
Derma Sciences, Inc. to Webcast June 17th Analy... [Published EON Science - Jun 13 2014]
Derma Sciences, Inc. to Webcast June 17th Analy... [Published Business Wire Science: Science News - Jun 13 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Derma Sciences to Present at Canaccord Genuity ... [Published EON Science - Aug 12 2014]
PRINCETON, N.J.--(EON: Enhanced Online News)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound care, announced today that Barry Wolfenson, the Company’s Group President, Advanced Wound Care and Pharmaceutical ...
Derma Sciences to Present at Canaccord Genuity ... [Published Business Wire Science: Science News - Aug 12 2014]
PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound care, announced today that Barry Wolfenson, the Company’s Group President, Advanced Wound Care and Pharmaceutical Development, ...
Derma Sciences to Present at Canaccord Genuity ... [Published Business Wire Health News - Aug 12 2014]
PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound care, announced today that Barry Wolfenson, the Company’s Group President, Advanced Wound Care and Pharmaceutical Development, ...
Derma Sciences Reports Second Quarter Financial... [Published Business Wire Health News - Aug 07 2014]
PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound and burn care, today reported financial and operating results for the three and six months ended June 30, 2014. Highlights of ...
Derma Sciences to Hold Second Quarter Financial... [Published Business Wire Health News - Aug 01 2014]
PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company focused on advanced wound care, announced today that it will hold a conference call on August 7, 2014 to discuss the financial results for the second quarter ...
1 2 3 4 5 6 7
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.